The outcome of babies of mothers with severe rhesus incompatibility treated at Tygerberg Hospital, 1980-1993.
OBJECTIVE
To determine the outcome of babies of mothers with severe rhesus (Rh) incompatibility treated by elective delivery when the amniotic optical density at 450 nm crossed Whitfield's action line (group 1), by plasmapheresis and immunotherapy (group 2) or by means of intra-uterine intravascular transfusions (group 3).


METHODS
A retrospective study of 55 mothers and their 57 fetuses with severe Rh incompatibility at < 34 weeks' pregnancy duration.


METHODS
Number of mothers in each treatment group, prevalence of intra-uterine death, hydrops, intra-uterine intravascular transfusions, cord haematocrit, cord bilirubin, number of liveborn babies, birth weight, neonatal death, hyaline membrane disease (HMD) and exchange transfusions.


METHODS
All mothers and babies with severe Rh incompatibility (defined as an amniotic optical density of 450 nm in the upper and upper-mid zone on the Liley chart at < 34 weeks' pregnancy duration, previous fetal hydrops or Rh-related intra-uterine death (IUD), fetal hydrops on ultrasound or a fetal haematocrit < 30% at cordocentesis) treated at Tygerberg Hospital between January 1980 and January 1993. There were 20 fetuses each in groups 1 and 3, and 17 in group 2.


RESULTS
A total of 48 babies (84%) were liveborn and of these 74% survived the neonatal period. (ABSTRACT TRUNCATED AT 250 WORDS)
Kirsten
G F
GF
Department of Paediatrics, MRC Perinatal Mortality Research Unit, Tygerberg, W. Cape.
Steyn
D W
DW
Muller
L
L
Geerts
L
L
Riphagen
S
S
de Beer
R
R
Kriel
J
J
Smith
J
J
Odendaal
H J
HJ
D000328:Adult; D004899:Erythroblastosis, Fetal / Q000276:immunology / Q000401:mortality; D005260:Female; D005313:Fetal Death / Q000209:etiology*; D006801:Humans; D015160:Hydrops Fetalis; D007231:Infant, Newborn; D011247:Pregnancy; D012203:Rh Isoimmunization / Q000517:prevention & control*; D012204:Rh-Hr Blood-Group System
D012204:Rh-Hr Blood-Group System